https://www.selleckchem.com/products/ABT-263.html
81 (1.20 to 2.72), p=0.005], nocebo-behaviour [1.19 (1.01-1.4, p=0.04] and current corticosteroid use [6.95 (1.75-27.59), p=0.006]. At the second visit, HADS-Depression and HADS-Anxiety scores were improved in 40.9% and 41.9% of patients, respectively. While no associations were found for HADS-Anxiety score change, changes in HADS-Depression score correlated with changes in subjective (tender joint count, r= 0.204, p=0.049; PtG, r= 0.236, p=0.023; patient pain assessment, r= 0.266, p=0.01) but not objective (swollen joint count, ESR,
Beğen
Yorum Yap
Paylaş
